SUMO1P3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.9302006094033E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
7.46560002706786E-09 |
Normal-vs-Stage2 |
1.498270E-02 |
Normal-vs-Stage3 |
3.7351000070629E-10 |
Normal-vs-Stage4 |
2.71059996670431E-09 |
Stage1-vs-Stage2 |
6.971200E-01 |
Stage1-vs-Stage3 |
4.212200E-02 |
Stage1-vs-Stage4 |
4.109600E-01 |
Stage2-vs-Stage3 |
1.614850E-01 |
Stage2-vs-Stage4 |
4.471800E-01 |
Stage3-vs-Stage4 |
2.338000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.37649899759163E-11 |
Normal-vs-AfricanAmerican |
2.597500E-03 |
Normal-vs-Asian |
2.30820000002296E-07 |
Caucasian-vs-AfricanAmerican |
9.884500E-03 |
Caucasian-vs-Asian |
5.661600E-02 |
AfricanAmerican-vs-Asian |
5.638600E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.57283083726634E-12 |
Normal-vs-Female |
2.63950000001234E-06 |
Male-vs-Female |
2.566300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.87299999954149E-08 |
Normal-vs-Age(41-60Yrs) |
4.13840000046406E-08 |
Normal-vs-Age(61-80Yrs) |
6.26669827141768E-11 |
Normal-vs-Age(81-100Yrs) |
7.406400E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.531800E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.271040E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.445580E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.922000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.795800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.596600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.070950E-01 |
Normal-vs-Grade 2 |
1.79381999999562E-05 |
Normal-vs-Grade 3 |
4.24820179034668E-11 |
Normal-vs-Grade 4 |
7.00273172782317E-12 |
Grade 1-vs-Grade 2 |
3.352800E-01 |
Grade 1-vs-Grade 3 |
6.832000E-02 |
Grade 1-vs-Grade 4 |
1.132470E-02 |
Grade 2-vs-Grade 3 |
3.084000E-02 |
Grade 2-vs-Grade 4 |
1.277430E-03 |
Grade 3-vs-Grade 4 |
8.014200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.77377999999173E-05 |
Normal-vs-ccB subtype |
1.62525548574877E-12 |
ccA subtype-vs-ccB subtype |
1.55716999999944E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.22060037025074E-10 |
Normal-vs-N1 |
2.18129999951522E-07 |
N0-vs-N1 |
2.181800E-01 |
|
|